Abatacept Post-marketing Clinical Study in Japan

• Status: Completed
• Trial end date: 2016-12-26

Summary

The purpose of this study is to compare the clinical efficacy including joint damage progression and safety of Abatacept plus Methotrexate (MTX) to placebo plus MTX.

• Phase: Phase 4

Details

• Lead Sponsor: Bristol-Myers Squibb
• Collaborator: Ono Pharmaceutical Co. Ltd
• Treatments: Abatacept; Methotrexate